Skip to main content
Fig. 1 | Journal of Experimental & Clinical Cancer Research

Fig. 1

From: Compound kushen injection suppresses human acute myeloid leukaemia by regulating the Prdxs/ROS/Trx1 signalling pathway

Fig. 1

The antioxidant CKI decreased intracellular ROS levels in AML cells. a Statistical analysis of the intracellular ROS levels after AML cells were treated with 110 μl/ml CKI for 24 h. b, c, d The ROS-related indexes were tested using AML cell supernatants and homogenates with kits as described in the methods. b T-AOC vitality. c GSH contents. d XOD vitality

Back to article page